Hemcheck Sweden AB has signed a 3-month evaluation agreement, starting in March 2021, with potential continuation into a 24-month long distribution agreement with Medtech Corporation…
Hemcheck Sweden AB has received a preliminary approval, a so-called Notice of Allowance, from the USPTO regarding Hemcheck’s design right application for its reader. When…
Hemcheck Sweden AB has signed an exclusive distribution agreement with Advanced Technology Company K.S.C.P. (“ATC”), one of the leading distributors of medical equipment in Kuwait….
Hemcheck Sweden AB has extended the evaluation agreement with Hemakim Tibbi Ürünler San.Ve Tic. A.S (”Hemakim”) to the end of May 2021. The evaluation agreement,…
The board of Hemcheck Sweden AB (publ) (“Hemcheck” or “The Company”) has, through the authorization given by the extra general meeting held on December 15th…
Hemcheck Sweden AB has signed an agreement with Capio S:t Göran’s hospital regarding delivery of readers and one-time disposables (v-Test) for usage at the emergency…
Hemcheck Sweden AB has gotten its patent application regarding the filter solution to receive and separate plasma from whole blood approved by the USPTO. –It’s…
Hemcheck Sweden AB has received a follow up order from the Foundation for Innovative New Diagnostics (FIND) regarding delivery of reader and one-time tests (v-Test)….
Hemcheck Sweden AB has signed a subscription agreement with Tartu university hospital regarding delivery of readers and one-time disposables (v-Test) for usage at the hematology…
Hemcheck Sweden AB has extended the evaluation agreement with Hemakim Tibbi Ürünler San.Ve Tic. A.S (”Hemakim”) to the end of 2020. The evaluation agreement that…
